Study: Statins may protect hep C patients from liver cancer

03/22/2013 | Reuters

The use of cholesterol-lowering statin drugs among patients with chronic hepatitis C was associated with a decreased risk of liver cancer, according to a study of around 261,000 patients in Taiwan. The reductions were modest, but the findings could address possible concerns about prescribing statins to patients with liver disease, a U.S. researcher commented. The study appeared in the Journal of Clinical Oncology.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN